Bone marrow banking and stem cell therapy platform for transplant centers
Ossium Health operates a bioengineered bone marrow banking and stem cell therapy platform, with active clinical trials and commercial launches underway. The tech stack reveals a healthcare-focused engineering approach: FHIR and OAuth 2.0 for interoperability, PostgreSQL + NoSQL for data persistence, and Python + Django for backend systems. Hiring velocity is accelerating across healthcare operations and manufacturing roles, while projects cluster around clinical trial execution (Preserve I/II launches, expanded access programs) and operational scaling—suggesting the company is transitioning from R&D into commercialization phase.
Notable leadership hires: Launch Operations Lead
Ossium Health develops bioengineered solutions for bone marrow banking, cryopreservation, and stem cell therapy targeting transplant centers and clinical institutions. Founded in 2016 and based in San Francisco, the company operates a 51–200 person team split between healthcare operations, engineering, manufacturing, and research functions. Current work centers on launching clinical programs (Preserve I long-term follow-up, Preserve II, Hope expanded access), improving material inspection and donor documentation processes, and scaling commercial adoption across transplant networks. Pain points center on regulatory compliance, cross-functional trial coordination, and readiness for multi-site product deployment.
Backend: Python, Django, Flask. Data: PostgreSQL, MySQL, NoSQL, SQL Server. Healthcare: FHIR, SMART on FHIR, OAuth 2.0, OpenID Connect. Infrastructure: Microsoft Office, Google Workspace, Rippling, Zoom.
Active projects include Preserve I long-term follow-up, Preserve II clinical trial launch, and Hope expanded access program, alongside vertebral body recovery program and internal system development.
Other companies in the same industry, closest in size